8-K
Current Report
Contineum Therapeutics, Inc. Filed Acc 0001628280-26-045804
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading ctnm-20260626.htm…